Literature DB >> 8103034

Renal effects of drugs used in the treatment of portal hypertension.

J H Henriksen, H Ring-Larsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8103034

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

1.  Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial.

Authors:  F Junquera; J C López-Talavera; F Mearin; E Saperas; S Videla; J R Armengol; R Esteban; J R Malagelada
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Effects of somatostatin on splanchnic hemodynamics in cirrhotic patients with portal hypertension.

Authors:  Ji-Ye Zhu; Xi-Sheng Leng; Dong Wang; Ru-Yu Du
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

Review 3.  Liver cirrhosis and arterial hypertension.

Authors:  Jens H Henriksen; Soren Moller
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

Review 4.  Hypertension and liver disease.

Authors:  Jens H Henriksen; Søren Møller
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

5.  Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.

Authors:  A J Stanley; I A Bouchier; P C Hayes
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

6.  Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites.

Authors:  M Sàbat; C Guarner; G Soriano; O Bulbena; M T Novella; J Ortiz; E Ricart; C Villanueva; J Rosello; J Rodríguez; J Balanzó
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

7.  Association of liver cirrhosis related IgA nephropathy with portal hypertension.

Authors:  Georgios Kalambokis; Leonidas Christou; Dimitrios Stefanou; Evdokia Arkoumani; Epameinondas V Tsianos
Journal:  World J Gastroenterol       Date:  2007-11-21       Impact factor: 5.742

8.  Very High Dose Epinephrine for the Treatment of Vasoplegic Syndrome during Liver Transplantation.

Authors:  M B Khosravi; S Milani; S Ghaffaripour; A Sahmeddini; M H Eghbal; S A Malek-Hosseini
Journal:  Int J Organ Transplant Med       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.